Incretin-Based Therapies in the Management of Type 2 Diabetes: Rationale and Reality in a Managed Care SettingByAlan J. Garber, MD, PhD, FACEAugust 20th 2010
Diabetes Pharmacy Management: Balancing Safety, Cost, and OutcomesByJeffrey D. Dunn, PharmD, MBAAugust 20th 2010
Improving Treatment Success Rates for Type 2 Diabetes: Recommendations for a Changing EnvironmentByCurtis Triplitt, PharmD, CDEAugust 20th 2010